GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (FRA:5HZ1) » Definitions » Return-on-Tangible-Asset

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Return-on-Tangible-Asset : 3.51% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Hangzhou Tigermed Consulting Co's annualized Net Income for the quarter that ended in Mar. 2024 was €120.1 Mil. Hangzhou Tigermed Consulting Co's average total tangible assets for the quarter that ended in Mar. 2024 was €3,423.7 Mil. Therefore, Hangzhou Tigermed Consulting Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 3.51%.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's Return-on-Tangible-Asset or its related term are showing as below:

FRA:5HZ1' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.38   Med: 14.28   Max: 16.95
Current: 6.38

During the past 13 years, Hangzhou Tigermed Consulting Co's highest Return-on-Tangible-Asset was 16.95%. The lowest was 6.38%. And the median was 14.28%.

FRA:5HZ1's Return-on-Tangible-Asset is ranked better than
77.35% of 234 companies
in the Medical Diagnostics & Research industry
Industry Median: -9.18 vs FRA:5HZ1: 6.38

Hangzhou Tigermed Consulting Co Return-on-Tangible-Asset Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Return-on-Tangible-Asset Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.98 14.36 15.16 8.56 7.71

Hangzhou Tigermed Consulting Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.11 12.28 7.30 2.17 3.51

Competitive Comparison of Hangzhou Tigermed Consulting Co's Return-on-Tangible-Asset

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Return-on-Tangible-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Return-on-Tangible-Asset falls into.



Hangzhou Tigermed Consulting Co Return-on-Tangible-Asset Calculation

Hangzhou Tigermed Consulting Co's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=260.047/( (3334.118+3409.17)/ 2 )
=260.047/3371.644
=7.71 %

Hangzhou Tigermed Consulting Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=120.124/( (3409.17+3438.257)/ 2 )
=120.124/3423.7135
=3.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Hangzhou Tigermed Consulting Co  (FRA:5HZ1) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Hangzhou Tigermed Consulting Co Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (FRA:5HZ1) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Headlines

No Headlines